Tumour Cell Growth Predicts Survival in B-cell Non-Hodgkin's Lymphomas
Author Information
Author(s): T Stokkel, EB Smeland, S Kvaloy, H Holte
Primary Institution: The Norwegian Radium Hospital
Hypothesis
Does the S-phase fraction of tumour cells provide prognostic value in B-cell non-Hodgkin's lymphomas?
Conclusion
The S-phase fraction is a strong prognostic indicator for survival in B-cell non-Hodgkin's lymphoma, while the apoptotic fraction does not predict survival.
Supporting Evidence
- S-phase fraction was found to be a significant prognostic indicator with a p-value of < 0.0001.
- The apoptotic fraction showed no prognostic value with a p-value of 0.85.
- Multivariate analysis indicated that S-phase fraction was the strongest predictor of survival.
- High tumour grade and age above 60 years were associated with poor prognosis.
Takeaway
This study found that how fast cancer cells are growing is important for predicting how long patients with a certain type of lymphoma will live, but how many cells are dying doesn't help us know that.
Methodology
Patients' tumour-specific apoptotic and S-phase fractions were assessed, and survival analysis was performed using Cox proportional hazards multivariate regression.
Limitations
The study may not account for all potential prognostic factors and relies on specific cut-off values for S-phase and apoptotic fractions.
Participant Demographics
The study involved 92 patients with B-cell non-Hodgkin's lymphoma, including 63 primary biopsy cases.
Statistical Information
P-Value
p=0.0003
Confidence Interval
1.9-9.6
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website